Exploring potential associations between blood metabolites and cirrhosis risk: a Mendelian randomization and LC–MS/MS analysis - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Investigating the Links Between Blood Metabolites and Cirrhosis Risk: A Mendelian Randomization and Targeted Metabolomics Approach

  • By

  • Duoduo Lv

  • Ning Han

  • Hong Tang

  • July 2, 2026

Share

Original Source(s)

Exploring potential associations between blood metabolites and cirrhosis risk: a Mendelian randomization and LC–MS/MS analysis

  • by Duoduo Lv, Ning Han, Hong Tang

  • July 2, 2026

Related Content

Editorial: Advancing immune research in chronic liver diseases through new approach methodologies

Correction: The gut-liver-immune axis: structural basis, cellular architecture, molecular mediators, and disease-specific manifestations

Cytokeratin-18 increase as a signal for early liver cell changes in high-fat diet-induced obesity before overt steatohepatitis